APIXABAN Side Effects

7019187-X | Colonic Polyp, Large Intestinal Haemorrhage
on Sep 15, 2010 Male patient from UNITED KINGDOM , 63 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: colonic polyp (What is colonic polyp?), large intestinal haemorrhage. Apixaban dosage: Interr On 14sep2010. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 14sep2010) (View Warfarin Sodium Review and Warfarin Sodium Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), MIGLITOL (View Miglitol Review and Miglitol Label ), SITAGLIPTIN PHOSPHATE (View Sitagliptin Phosphate Review and Sitagliptin Phosphate Label ). Patient was hospitalized.

6984857-6 | Gastrointestinal Necrosis, Mesenteric Artery Embolism
Patient was taking Apixaban (View Usage). Patient had the following side effects: gastrointestinal necrosis, mesenteric artery embolism on Sep 08, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 77 years of age, was diagnosed with thrombosis prophylaxis and. Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CO RENITEC (View Co-renitec Review and Co-renitec Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6939200-5 | Spinal Compression Fracture
Adverse event was reported on Aug 12, 2010 by a Female patient taking Apixaban (View Usage) (Dosage: Interrupted On 02jul2010) was diagnosed with thrombosis prophylaxis and. Location: UNITED KINGDOM , 79 years of age, weighting 88.18 lb, After Apixaban was administered, patient had the following side effects: spinal compression fracture. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 02jul2010) (View Warfarin Sodium Review and Warfarin Sodium Label ), MOSAPRIDE CITRATE (View Mosapride Citrate Review and Mosapride Citrate Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ), VITANEURIN (View Vitaneurin Review and Vitaneurin Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ). Patient was hospitalized.

6936855-6 | Aortic Aneurysm Rupture
on Aug 12, 2010 Male patient from UNITED KINGDOM , 80 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: aortic aneurysm rupture. Apixaban dosage: Interrupted On 12aug10. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 12aug10) (View Warfarin Sodium Review and Warfarin Sodium Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ). Patient was hospitalized.


6926127-8 | Aortic Aneurysm Rupture
on Aug 12, 2010 Male patient from UNITED KINGDOM , 80 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient had the following side effects: aortic aneurysm rupture. Apixaban dosage: Interrupted On 12aug10. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 12aug10) (View Warfarin Sodium Review and Warfarin Sodium Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ).

6922012-6 | Blood Bilirubin Increased, Gilbert's Syndrome
Patient was taking Apixaban (View Usage). After Apixaban was administered, patient had the following side effects: blood bilirubin increased, gilbert's syndrome on Aug 03, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 70 years of age, weighting 207.2 lb, was diagnosed with embolism arterial and. Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (2-4 Mg Daily) (View Warfarin Sodium Review and Warfarin Sodium Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), MUTAFLOR (View Mutaflor Review and Mutaflor Label ).

6880806-X | Gastrointestinal Necrosis, Mesenteric Artery Embolism
Adverse event was reported on Jul 19, 2010 by a Male patient taking Apixaban (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: UNITED KINGDOM , 77 years of age, Patient experienced the following unwanted or unexpected effects: gastrointestinal necrosis, mesenteric artery embolism. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CO RENITEC (View Co-renitec Review and Co-renitec Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6847841-9 | Gastrointestinal Necrosis, Mesenteric Artery Embolism
on Jul 07, 2010 Male patient from UNITED KINGDOM , 77 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient had the following side effects: gastrointestinal necrosis, mesenteric artery embolism. Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CO RENITEC (View Co-renitec Review and Co-renitec Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6832033-X | Psoriasis
on Jun 30, 2010 Male patient from UNITED KINGDOM , 71 years of age, was diagnosed with thrombosis prophylaxis, cardiac disorder, hypertension and was treated with Apixaban (View Usage). After Apixaban was administered, patient had the following side effects: psoriasis. Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (Variable Total Daily Dose) (View Warfarin Sodium Review and Warfarin Sodium Label ), ACETYLSALICYLIC ACID (Ass 100 Prestudy/ongoing) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), RAMIPRIL (Prestudy/ongoing) (View Ramipril Review and Ramipril Label ), BISOPROLOL (Prestudy/ongoing) (View Bisoprolol Review and Bisoprolol Label ), HYDROCHLOROTHIAZIDE (Prestudy/ongoing) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), SPIRONOLACTONE (Prestudy/ongoing) (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (Prestudy/ongoing) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6827110-3 | Gastrointestinal Necrosis, Mesenteric Artery Embolism
Patient was taking Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal necrosis, mesenteric artery embolism on Jul 07, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 77 years of age, was diagnosed with thrombosis prophylaxis and. Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CO RENITEC (View Co-renitec Review and Co-renitec Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

6814401-5 | Convulsion, Transient Ischaemic Attack
Adverse event was reported on Jun 28, 2010 by a Male patient taking Apixaban (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: UNITED STATES , 67 years of age, Patient had the following side effects: convulsion, transient ischaemic attack. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LANOXIN (1/2 Tab Per Tab) (View Lanoxin Review and Lanoxin Label ), NORTAN (Form = Tabs) (View Nortan Review and Nortan Label ), ALDAZIDE (Formulation- Tablet) (View Aldazide Review and Aldazide Label ), NEOBLOC (Formulation - Tablet Strength = 50mg 1 Dosageform = 1/2 Tab) (View Neobloc Review and Neobloc Label ), ELTROXIN (Form = Tabs Strength 50 Mg) (View Eltroxin Review and Eltroxin Label ), ISOSORBIDE DINITRATE (Form = Tabs Strength 10 Mg 1 Dosageform = 1/2 Tabs) (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ).

6810260-5 | Cardiac Arrest, Ischaemic Stroke, Tubulointerstitial Nephritis
on Jun 18, 2010 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). After Apixaban was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), ischaemic stroke, tubulointerstitial nephritis. Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (Interrupted On 29mar09) (View Warfarin Sodium Review and Warfarin Sodium Label ), DIGOXIN TABS (View Digoxin Tabs Review and Digoxin Tabs Label ), RAMIPRIL (Tabs) (View Ramipril Review and Ramipril Label ), METOPROLOL (Tabs) (View Metoprolol Review and Metoprolol Label ), LASIX (Tabs) (View Lasix Review and Lasix Label ), RANOLAZINE HCL (Tabs) (View Ranolazine Hcl Review and Ranolazine Hcl Label ), ALDOSTERONE (Tabs) (View Aldosterone Review and Aldosterone Label ). Patient was hospitalized.

6772762-X | Psoriasis
on Jun 09, 2010 Male patient from UNITED KINGDOM , 71 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: psoriasis. Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (Variable Total Daily Dose) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6754609-0 | Hepatotoxicity, Urinary Tract Infection
Patient was taking Apixaban (View Usage). Patient had the following side effects: hepatotoxicity, urinary tract infection (What is urinary tract infection?) on May 24, 2010 from UNITED STATES Additional patient health information: Male patient , 78 years of age, was diagnosed with thrombosis prophylaxis and. Apixaban dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), ACERTIL (View Acertil Review and Acertil Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ). Patient was hospitalized.

6754608-9 | Hepatotoxicity, Urinary Tract Infection
Adverse event was reported on May 24, 2010 by a Male patient taking Apixaban (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: UNITED STATES , 78 years of age, After Apixaban was administered, patient had the following side effects: hepatotoxicity, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), ACERTIL (View Acertil Review and Acertil Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ). Patient was hospitalized.

6749096-2 | Haematuria
on May 24, 2010 Female patient from UNITED KINGDOM , 68 years of age, was diagnosed with thrombosis prophylaxis, hypertension, vitamin supplementation and was treated with Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: haematuria. Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), AMLODIPINE (Tablet Form) (View Amlodipine Review and Amlodipine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LANOXIN (Tabs) (View Lanoxin Review and Lanoxin Label ), ESOMEPRAZOLE MAGNESIUM (Capsule Form) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), RAMIPRIL (Tablet Form) (View Ramipril Review and Ramipril Label ), MULTI VITAMIN (1 Capsule) (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

6743353-1 | Aortic Dissection, Haemothorax, Pneumonia
on May 19, 2010 Male patient from UNITED KINGDOM , 67 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient had the following side effects: aortic dissection, haemothorax, pneumonia (What is pneumonia?). Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), IMIDAPRIL HCL (View Imidapril Hcl Review and Imidapril Hcl Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ). Patient was hospitalized.

6743322-1 | Cerebral Infarction
Patient was taking Apixaban (View Usage). After Apixaban was administered, patient had the following side effects: cerebral infarction on May 20, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 78 years of age, was diagnosed with thrombosis prophylaxis and. Apixaban dosage: Interrupted 20-apr-2009. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 20apr09) (View Warfarin Sodium Review and Warfarin Sodium Label ), MANNITOL (View Mannitol Review and Mannitol Label ), CITICOLINE (View Citicoline Review and Citicoline Label ), FRUCTOSE (View Fructose Review and Fructose Label ), GLYCEROL (View Glycerol Review and Glycerol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6720075-4 | Psoriasis
Adverse event was reported on Apr 29, 2010 by a Male patient taking Apixaban (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: UNITED KINGDOM , 71 years of age, Patient experienced the following unwanted or unexpected effects: psoriasis. During the same period patient was treated with WARFARIN SODIUM (Variable Total Daily Dose) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6713942-9 | Alanine Aminotransferase Increased, Aortic Dissection, Aortic Thrombosis, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Increased, Contrast Media Reaction, Haemothorax, Pneumonia
on Apr 29, 2010 Male patient from UNITED KINGDOM , 67 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient had the following side effects: alanine aminotransferase increased, aortic dissection, aortic thrombosis, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood pressure increased, contrast media reaction, haemothorax, pneumonia (What is pneumonia?). Apixaban dosage: Interrupted 21may09. During the same period patient was treated with WARFARIN SODIUM (Interrupted 21may09) (View Warfarin Sodium Review and Warfarin Sodium Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), IMIDAPRIL HCL (View Imidapril Hcl Review and Imidapril Hcl Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ). Patient was hospitalized.

6711941-4 | Mallory-weiss Syndrome, Upper Gastrointestinal Haemorrhage
on May 03, 2010 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). After Apixaban was administered, patient had the following side effects: mallory-weiss syndrome, upper gastrointestinal haemorrhage. Apixaban dosage: 1df=2 (units Not Specified) Interrupted On 13mar2010; Restart On 30mar2010. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 13mar2010; Restart 19mar2010) (View Warfarin Sodium Review and Warfarin Sodium Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6704391-8 | Haematoma, Synovial Rupture
Patient was taking Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma, synovial rupture on Apr 19, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 81 years of age, was diagnosed with thrombosis prophylaxis and. Apixaban dosage: Interrupted On 24mar10, Restarted On 08apr10, Held X3 Days On 09apr10, Restared 12apr10. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 24mar10, Restarted On 08apr10, Held X3 Days On 09apr10, Restared (4 Mg) 12apr10) (View Warfarin Sodium Review and Warfarin Sodium Label ), CARDIOMAGNYL (View Cardiomagnyl Review and Cardiomagnyl Label ), ENAP (View Enap Review and Enap Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), VEROSPIRON (View Verospiron Review and Verospiron Label ). Patient was hospitalized.

6701269-0 | Mallory-weiss Syndrome, Upper Gastrointestinal Haemorrhage
Adverse event was reported on Apr 19, 2010 by a Male patient taking Apixaban (View Usage) (Dosage: 1df=2 (units Not Specified) Interrupted On 13mar2010; Restart On 30mar2010) was diagnosed with thrombosis prophylaxis and. Location: UNITED KINGDOM , 65 years of age, Patient had the following side effects: mallory-weiss syndrome, upper gastrointestinal haemorrhage. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 13mar2010; Restart 19mar2010) (View Warfarin Sodium Review and Warfarin Sodium Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6663913-6 | Ischaemic Stroke, Pneumonia
on Mar 25, 2010 Male patient from UNITED STATES , 73 years of age, weighting 178.6 lb, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). After Apixaban was administered, patient had the following side effects: ischaemic stroke, pneumonia (What is pneumonia?). Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6653690-7 | Bronchopneumonia, Cardiopulmonary Failure, Pulmonary Haemorrhage, Upper Gastrointestinal Haemorrhage
on Mar 22, 2010 Male patient from UNITED KINGDOM , 79 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopneumonia, cardiopulmonary failure, pulmonary haemorrhage, upper gastrointestinal haemorrhage. Apixaban dosage: . During the same period patient was treated with COUMADIN (Interrupted Date: 15-sep-08) (View Coumadin Review and Coumadin Label ), METOPROLOL (50 Mp) (View Metoprolol Review and Metoprolol Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), SERENOA REPENS (View Serenoa Repens Review and Serenoa Repens Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.

6651707-7 | Ischaemic Stroke, Pneumonia
Patient was taking Apixaban (View Usage). Patient had the following side effects: ischaemic stroke, pneumonia (What is pneumonia?) on Mar 17, 2010 from UNITED STATES Additional patient health information: Male patient , 73 years of age, weighting 178.6 lb, was diagnosed with thrombosis prophylaxis and. Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6641171-6 | Polyneuropathy, Respiratory Failure, Viral Infection
Adverse event was reported on Mar 08, 2010 by a Female patient taking Apixaban (View Usage) (Dosage: ) was diagnosed with embolism and. Location: UNITED KINGDOM , 70 years of age, After Apixaban was administered, patient had the following side effects: polyneuropathy, respiratory failure, viral infection (What is viral infection?). During the same period patient was treated with WARFARIN SODIUM (Interrupted On 08-feb-10) (View Warfarin Sodium Review and Warfarin Sodium Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), DELTACORTENE (Tapering Dose) (View Deltacortene Review and Deltacortene Label ), MICARDIS (View Micardis Review and Micardis Label ), SIMVACOR (View Simvacor Review and Simvacor Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized and became disabled.

6620955-4 | Neuropathy Peripheral
on Feb 25, 2010 Male patient from MEXICO , 84 years of age, was diagnosed with thrombosis prophylaxis, cardiac failure, pain in extremity, hypertension, venous insufficiency and was treated with Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: neuropathy peripheral. Apixaban dosage: Interrupted 31jan10 To 08feb10. During the same period patient was treated with WARFARIN SODIUM (Interrupted 31jan10 To 08feb10) (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), PENTOXIFYLLINE (View Pentoxifylline Review and Pentoxifylline Label ). Patient was hospitalized.

6612206-1 | Ataxia, Polyneuropathy, Respiratory Failure, Viral Infection
on Feb 19, 2010 Female patient from UNITED KINGDOM , 70 years of age, was diagnosed with embolism and was treated with Apixaban (View Usage). Patient had the following side effects: ataxia (What is ataxia?), polyneuropathy, respiratory failure, viral infection (What is viral infection?). Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (Interrupted On 08-feb-10) (View Warfarin Sodium Review and Warfarin Sodium Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), DELTACORTENE (Tapering Dose) (View Deltacortene Review and Deltacortene Label ), MICARDIS (View Micardis Review and Micardis Label ), SIMVACOR (View Simvacor Review and Simvacor Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ).

6610980-1 | Aortic Dissection, Haemothorax, Pneumonia
Patient was taking Apixaban (View Usage). After Apixaban was administered, patient had the following side effects: aortic dissection, haemothorax, pneumonia (What is pneumonia?) on Feb 22, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 67 years of age, was diagnosed with thrombosis prophylaxis and. Apixaban dosage: Interrupted 21may09. During the same period patient was treated with WARFARIN SODIUM (Interrupted 21may09) (View Warfarin Sodium Review and Warfarin Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), IMIDAPRIL HCL (View Imidapril Hcl Review and Imidapril Hcl Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ). Patient was hospitalized.

6591114-9 | Polyneuropathy, Respiratory Failure, Viral Infection
Adverse event was reported on Feb 09, 2010 by a Female patient taking Apixaban (View Usage) (Dosage: ) was diagnosed with embolism and. Location: UNITED KINGDOM , 70 years of age, Patient experienced the following unwanted or unexpected effects: polyneuropathy, respiratory failure, viral infection (What is viral infection?). During the same period patient was treated with WARFARIN SODIUM (Interrupted On 08-feb-10) (View Warfarin Sodium Review and Warfarin Sodium Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), DELTACORTENE (Tapering Dose) (View Deltacortene Review and Deltacortene Label ), MICARDIS (View Micardis Review and Micardis Label ), SIMVACOR (View Simvacor Review and Simvacor Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ).

6552279-8 | Ischaemic Stroke
on Jan 18, 2010 Male patient from UNITED STATES , 71 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient had the following side effects: ischaemic stroke. Apixaban dosage: Interrupted On 05dec09. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 04dec09) (View Warfarin Sodium Review and Warfarin Sodium Label ), ESPIRONOLACTONA (View Espironolactona Review and Espironolactona Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

6546243-2 | Aortic Aneurysm Rupture
on Jan 11, 2010 Female patient from UNITED KINGDOM , 90 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). After Apixaban was administered, patient had the following side effects: aortic aneurysm rupture. Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ).

6540059-9 | Deep Vein Thrombosis, Large Intestinal Ulcer
Patient was taking Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), large intestinal ulcer on Jan 06, 2010 from UNITED STATES Additional patient health information: Female patient , 65 years of age, was diagnosed with thrombosis prophylaxis and. Apixaban dosage: 2 Df - 2tabs Interrupted 14nov09 To 18nov09. During the same period patient was treated with WARFARIN SODIUM (4 Mg Daily Except 6 Mg On Friday Interrupted 14nov09 To 18nov09) (View Warfarin Sodium Review and Warfarin Sodium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), NORVASC (View Norvasc Review and Norvasc Label ), ZOCOR (View Zocor Review and Zocor Label ), LYRICA (View Lyrica Review and Lyrica Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LISINOPRIL (1 Df = 20/25) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6538956-3 | Aortic Aneurysm Rupture
Adverse event was reported on Jan 11, 2010 by a Female patient taking Apixaban (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: UNITED KINGDOM , 90 years of age, Patient had the following side effects: aortic aneurysm rupture. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ).

6537928-2 | Ischaemic Stroke
on Jan 04, 2010 Male patient from UNITED STATES , 71 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). After Apixaban was administered, patient had the following side effects: ischaemic stroke. Apixaban dosage: Interrupted On Dec09. During the same period patient was treated with WARFARIN SODIUM (Interrupted On Dec09) (View Warfarin Sodium Review and Warfarin Sodium Label ), ESPIRONOLACTONA (View Espironolactona Review and Espironolactona Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

6531827-8 | Ischaemic Stroke
on Jan 04, 2010 Male patient from UNITED STATES , 71 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: ischaemic stroke. Apixaban dosage: Interrupted On Dec09. During the same period patient was treated with WARFARIN SODIUM (Interrupted On Dec09) (View Warfarin Sodium Review and Warfarin Sodium Label ), ESPIRONOLACTONA (View Espironolactona Review and Espironolactona Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

6525693-4 | Renal Failure Acute, Therapeutic Agent Toxicity
Patient was taking Apixaban (View Usage). Patient had the following side effects: renal failure acute, therapeutic agent toxicity on Dec 21, 2009 from UNITED STATES Additional patient health information: Female patient , 66 years of age, was diagnosed with thrombosis prophylaxis, gout (What is gout?) and. Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6438055-5 | Aortic Dissection, Haemothorax, Pneumonia
Adverse event was reported on Nov 06, 2009 by a Male patient taking Apixaban (View Usage) (Dosage: Interrupted 21may09) was diagnosed with thrombosis prophylaxis and. Location: UNITED KINGDOM , 67 years of age, After Apixaban was administered, patient had the following side effects: aortic dissection, haemothorax, pneumonia (What is pneumonia?). During the same period patient was treated with WARFARIN SODIUM (Interrupted 21may09) (View Warfarin Sodium Review and Warfarin Sodium Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), IMIDAPRIL HCL (View Imidapril Hcl Review and Imidapril Hcl Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ). Patient was hospitalized.

6432943-1 | Aortic Dissection, Aortic Dissection Rupture, Haemothorax, Pneumonia, Pneumonia Staphylococcal, Renal Failure Acute
on Nov 02, 2009 Male patient from UNITED KINGDOM , 67 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: aortic dissection, aortic dissection rupture, haemothorax, pneumonia (What is pneumonia?), pneumonia staphylococcal, renal failure acute. Apixaban dosage: Interrupted 21may09. During the same period patient was treated with WARFARIN SODIUM (Interrupted 21may09) (View Warfarin Sodium Review and Warfarin Sodium Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), IMIDAPRIL HCL (View Imidapril Hcl Review and Imidapril Hcl Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ). Patient was hospitalized.

6422064-6 | Haemorrhage, Overdose, Paralysis
on Oct 19, 2009 Male patient from UNITED KINGDOM , 75 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient had the following side effects: haemorrhage, overdose, paralysis (What is paralysis?). Apixaban dosage: Interrupted 06-oct-2009. During the same period patient was treated with WARFARIN SODIUM (Interrupted 25-sep-2009) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6413316-4 | Cerebral Infarction
Patient was taking Apixaban (View Usage). After Apixaban was administered, patient had the following side effects: cerebral infarction on Oct 20, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 78 years of age, was diagnosed with thrombosis prophylaxis and. Apixaban dosage: Interrupted 20-apr-2009. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 20apr09) (View Warfarin Sodium Review and Warfarin Sodium Label ), MANNITOL (View Mannitol Review and Mannitol Label ), CITICOLINE (View Citicoline Review and Citicoline Label ), FRUCTOSE (View Fructose Review and Fructose Label ), GLYCEROL 2.6% (View Glycerol 2.6% Review and Glycerol 2.6% Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6405869-7 | Vascular Pseudoaneurysm
Adverse event was reported on Oct 14, 2009 by a Male patient taking Apixaban (View Usage) (Dosage: Interrupted On 04sep09) was diagnosed with thrombosis prophylaxis and. Location: UNITED STATES , 64 years of age, Patient experienced the following unwanted or unexpected effects: vascular pseudoaneurysm. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 04sep09) (View Warfarin Sodium Review and Warfarin Sodium Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6405035-5 | Vascular Pseudoaneurysm
on Oct 06, 2009 Male patient from UNITED STATES , 64 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient had the following side effects: vascular pseudoaneurysm. Apixaban dosage: Interrupted On 04sep09. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 04sep09) (View Warfarin Sodium Review and Warfarin Sodium Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6402054-X | Bronchopneumonia, Cardiopulmonary Failure, Pulmonary Haemorrhage, Upper Gastrointestinal Haemorrhage
on Oct 06, 2009 Male patient from UNITED KINGDOM , 79 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). After Apixaban was administered, patient had the following side effects: bronchopneumonia, cardiopulmonary failure, pulmonary haemorrhage, upper gastrointestinal haemorrhage. Apixaban dosage: . During the same period patient was treated with COUMADIN (Interrupted Date: 15-sep-08) (View Coumadin Review and Coumadin Label ), METOPROLOL (50 Mp) (View Metoprolol Review and Metoprolol Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), SERENOA REPENS (View Serenoa Repens Review and Serenoa Repens Label ), CIPROFLOXACIN HYDROCHLORIDE (View Ciprofloxacin Hydrochloride Review and Ciprofloxacin Hydrochloride Label ). Patient was hospitalized.

6396574-4 | Cardiac Failure Congestive, Cardiomyopathy, Liver Function Test Abnormal, Myocarditis, Sepsis
Patient was taking Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?), liver function test abnormal, myocarditis, sepsis (What is sepsis?) on Oct 06, 2009 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 125.7 lb, was diagnosed with thrombosis prophylaxis, hypertension, heart rate, dyslipidaemia and. Apixaban dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), COREG (View Coreg Review and Coreg Label ), BYSTOLIC (5 Mg Morning; 2.5 Mg Evening.) (View Bystolic Review and Bystolic Label ), LIPITOR (View Lipitor Review and Lipitor Label ), BENICAR HCT (1df= 20/12.5mg) (View Benicar Hct Review and Benicar Hct Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ).

6361697-2 | Aortic Aneurysm
Adverse event was reported on Sep 08, 2009 by a Male patient taking Apixaban (View Usage) (Dosage: Interrupted On 04sep09) was diagnosed with thrombosis prophylaxis and. Location: UNITED STATES , 64 years of age, Patient had the following side effects: aortic aneurysm (What is aortic aneurysm?). During the same period patient was treated with WARFARIN SODIUM (Interrupted On 04sep09) (View Warfarin Sodium Review and Warfarin Sodium Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6356736-9 | Convulsion, Transient Ischaemic Attack
on Sep 04, 2009 Male patient from UNITED STATES , 67 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). After Apixaban was administered, patient had the following side effects: convulsion, transient ischaemic attack. Apixaban dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LANOXIN (1/2 Tab Per Tab) (View Lanoxin Review and Lanoxin Label ), NORTAN (Form = Tabs) (View Nortan Review and Nortan Label ), ALDAZIDE (Formulation- Tablet) (View Aldazide Review and Aldazide Label ), NEOBLOC (Formulation - Tablet Strength = 50mg 1 Dosageform = 1/2 Tab) (View Neobloc Review and Neobloc Label ), ELTROXIN (Form = Tabs Strength 50 Mg) (View Eltroxin Review and Eltroxin Label ), ISOSORBIDE DINITRATE (Form = Tabs Strength 10 Mg 1 Dosageform = 1/2 Tabs) (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ).

6325920-2 | Convulsion
on Aug 12, 2009 Male patient from UNITED STATES , 67 years of age, was diagnosed with thrombosis prophylaxis and was treated with Apixaban (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Apixaban dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LANOXIN (1/2 Tab Per Tab) (View Lanoxin Review and Lanoxin Label ), NORTAN (Form = Tabs) (View Nortan Review and Nortan Label ), ALDAZIDE (Formulation- Tablet) (View Aldazide Review and Aldazide Label ), NEOBLOC (Formulation - Tablet Strength = 50mg 1 Dosageform = 1/2 Tab) (View Neobloc Review and Neobloc Label ), ELTROXIN (Form = Tabs Strength 50 Mg) (View Eltroxin Review and Eltroxin Label ), ISOSORBIDE DINITRATE (Form = Tabs Strength 10 Mg 1 Dosageform = 1/2 Tabs) (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ).

6316934-7 | Hepatitis Acute
Patient was taking Apixaban (View Usage). Patient had the following side effects: hepatitis acute on Aug 17, 2009 from MEXICO Additional patient health information: Male patient , 63 years of age, was diagnosed with thrombosis prophylaxis, cardiac failure, hypertension and. Apixaban dosage: Interrupted On 29-jul-09. During the same period patient was treated with WARFARIN SODIUM (Interrupted On 29-jul-2009) (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.